T3 Defense soars 201% as subsidiary expands into industrial materials

NextCure rose 20.75% in a move tied to a significant short squeeze, highlighting how positioning can amplify gains in heavily shorted stocks.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.